Patient selection for migraine preventive treatment with anti-CGRP (r) monoclonal antibodies
A Negro, P Martelletti - Expert Review of Neurotherapeutics, 2019 - Taylor & Francis
Introduction: Migraine is the most common neurological disorder and represents the first
cause of disability in under 50s in both genders. Available preventive drugs were primarily …
cause of disability in under 50s in both genders. Available preventive drugs were primarily …
Patient selection for migraine preventive treatment with anti-CGRP (r) monoclonal antibodies
A Negro, P Martelletti - Expert review of neurotherapeutics, 2019 - pubmed.ncbi.nlm.nih.gov
Introduction: Migraine is the most common neurological disorder and represents the first
cause of disability in under 50s in both genders. Available preventive drugs were primarily …
cause of disability in under 50s in both genders. Available preventive drugs were primarily …
Patient selection for migraine preventive treatment with anti-CGRP (r) monoclonal antibodies.
A Negro, P Martelletti - Expert Review of Neurotherapeutics, 2019 - europepmc.org
Introduction: Migraine is the most common neurological disorder and represents the first
cause of disability in under 50s in both genders. Available preventive drugs were primarily …
cause of disability in under 50s in both genders. Available preventive drugs were primarily …
Patient selection for migraine preventive treatment with anti-CGRP (r) monoclonal antibodies
A Negro, P Martelletti - EXPERT REVIEW OF …, 2019 - iris.uniroma1.it
Introduction: Migraine is the most common neurological disorder and represents the first
cause of disability in under 50s in both genders. Available preventive drugs were primarily …
cause of disability in under 50s in both genders. Available preventive drugs were primarily …